ONE PILL, ONCE A DAY GET TO KNOW AUBAGIO. Ask your doctor if AUBAGIO may be right for you. Patient Portrayal

Size: px
Start display at page:

Download "ONE PILL, ONCE A DAY GET TO KNOW AUBAGIO. Ask your doctor if AUBAGIO may be right for you. Patient Portrayal"

Transcription

1 ONE PILL, ONCE A DAY GET TO KNOW AUBAGIO Patient Portrayal Ask your doctor if AUBAGIO may be right for you. INDICATION AUBAGIO (teriflunomide) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS). IMPORTANT SAFETY INFORMATION Do not take AUBAGIO if you have severe liver problems, are pregnant or of childbearing potential and not using effective birth control, have had an allergic reaction to AUBAGIO or leflunomide, or are taking a medicine called leflunomide for rheumatoid arthritis. Please see Important Safety Information on pages 30 and 31 and accompanying full Prescribing Information, including boxed WARNING and Medication Guide.

2 TABLE OF CONTENTS ABOUT AUBAGIO ONE SMALL PILL, ONCE A DAY WHO IS AUBAGIO FOR? CLINICAL RESULTS CLINICAL TRIALS RELAPSES DISABILITY PROGRESSION LESIONS GETTING STARTED TODAY IS A NEW BEGINNING FIRST THINGS FIRST GET SUPPORT THAT S TRULY PERSONAL FINANCIAL ASSISTANCE SUPPORT IS JUST A PHONE CALL AWAY HELPFUL RESOURCES IMPORTANT SAFETY INFORMATION LEARN MORE AUBAGIO IN THE BODY ABOUT POTENTIAL SIDE EFFECTS 3 QUESTIONS COVER A LOT CHECK OUT A LIVE EVENT $0 CO-PAY PROGRAM

3 QUIETS RELAPSES The majority of patients taking AUBAGIO did not experience a relapse during clinical studies. QUIETS DISABILITY PROGRESSION 80% of patients taking AUBAGIO 14 mg experienced no disability progression. QUIETS NEW LESIONS AUBAGIO 14 mg cut the risk of new lesions by 80%. Patient Portrayal * AUBAGIO (teriflunomide) is effective across key measures of disease activity: sustained disability progression (14 mg only), annualized relapse rate, and MRI activity. Overall discontinuation rates due to adverse events were 12.5% with AUBAGIO 14 mg, 11.2% with AUBAGIO 7 mg, and 7.5% with placebo, and discontinuation rates due to common adverse events were 3.3% in the pooled clinical trials. Doctors measure disability progression using a test called the Expanded Disability Status Scale, or EDSS. Your first score or your baseline will determine how your disability is gauged moving forward. If your baseline score is 5.5, you re considered to have sustained disability progression if that score goes up by one point (lasting at least 12 weeks). If your baseline score is >5.5, you re considered to have sustained disability progression if that score goes up by at least 0.5 point (lasting at least 12 weeks). AUBAGIO may stay in your blood for up to 2 years after you stop taking it. Your healthcare provider can prescribe a medicine that can remove AUBAGIO from your blood quickly. 14 mg only. Please see Important Safety Information on pages 30 and 31 and accompanying full Prescribing Information, including boxed WARNING and Medication Guide. ABOUT AUBAGIO

4 ONE SMALL PILL, ONCE A DAY TAKE IT ANYTIME, WITH OR WITHOUT FOOD Taking AUBAGIO (teriflunomide) is one way you may be able to help put your relapsing MS in the background. Your healthcare provider will run certain tests before you start treatment. Once on AUBAGIO, your healthcare provider will monitor your liver enzyme levels monthly for the first 6 months. 4 Please see Important Safety Information on pages 30 and 31 and accompanying full Prescribing Information, including boxed WARNING and Medication Guide. ABOUT AUBAGIO

5 medication used to weigh on me. Now I take one pill in the morning and then I don t think about it. Darin Taking On AUBAGIO 14 mg Individual experiences may vary AUBAGIO (TERIFLUNOMIDE) IS AN OPTION FOR PEOPLE LIVING WITH RELAPSING MS WHO ARE: Newly diagnosed or have never used treatment Changing therapies because of side effects from current MS medication Switching Switching therapies therapies due due to to disease activity Dissatisfied with their current treatment Before taking AUBAGIO, talk with your healthcare provider if you have: liver or kidney problems; a fever or infection, or if you are unable to fight infections; numbness or tingling in your hands or feet that is different from your MS symptoms; diabetes; serious skin problems when taking other medicines; breathing problems; or high blood pressure. Your healthcare provider will check your blood cell count and TB test before you start AUBAGIO. Talk with your healthcare provider if you take or are planning to take other medicines (especially medicines for treating cancer or controlling your immune system), vitamins or herbal supplements. Please see Important Safety Information on pages 30 and 31 and accompanying full Prescribing Information, including boxed WARNING and Medication Guide. ABOUT AUBAGIO

6 CLINICAL RESULTS Patient Portrayal AUBAGIO may cause serious side effects, including: reduced white blood cell count this may cause you to have more infections; numbness or tingling in your hands or feet that is different from your MS symptoms; allergic reactions, including serious skin problems; breathing problems (new or worsening); and high blood pressure. Patients with low white blood cell count should not receive certain vaccinations during AUBAGIO treatment and 6 months after. Tell your doctor if you have any side effect that bothers you or does not go away. Please see Important Safety Information on pages 30 and 31 and accompanying full Prescribing Information, including boxed WARNING and Medication Guide. IN 3 CLINICAL TRIALS, AUBAGIO WAS PROVEN EFFECTIVE CLINICAL RESULTS CLINICAL RESULTS CLINICAL RESULTS

7 PROVEN IN 3 CLINICAL TRIALS AUBAGIO (teriflunomide) WAS STUDIED In 3 CLINICAL TRIALS With more than 2,800 PATIENTS For up to 108 WEEKS In doses of 14 mg & 7 mg AUBAGIO 14 mg was shown to be effective vs. placebo in 3 key measures: relapses, disability progression and brain lesions. AUBAGIO 7 mg was shown to be effective vs. placebo in 2 of the 3 key measures relapses and brain lesions. The most common side effects when taking AUBAGIO include: headache; diarrhea; nausea; hair thinning or loss; and abnormal liver test results. These are not all the side effects of AUBAGIO. Tell your healthcare provider about any side effect that bothers you. Please see Important Safety Information on pages 30 and 31 and accompanying full Prescribing Information, including boxed WARNING and Medication Guide. CLINICAL RESULTS

8 1ST CLINICAL T R I A L* TEMSO 1,088 PATIENTS who had at least 1 relapse during 1 year prior to trial, or 2 relapses during 2 years prior to trial 2ND CLINICAL T R I A L* TOWER 1,165 PATIENTS who had at least 1 relapse during 1 year prior to trial, or 2 relapses during 2 years prior to trial 3RD CLINICAL T R I A L* TOPIC 614 PATIENTS who had their 1st clinical event within 3 months prior to trial, and 2 or more lesions characteristic of relapsing MS *The clinical trials were each given a name. Trial 1 was called TEMSO; Trial 2 was called TOWER; and Trial 3 was called TOPIC. Do not take AUBAGIO if you have severe liver problems, are pregnant or of childbearing potential and not using effective birth control, have had an allergic reaction to AUBAGIO or leflunomide, or are taking a medicine called leflunomide for rheumatoid arthritis. Patient Portrayal Please see Important Safety Information on pages 30 and 31 and accompanying full Prescribing Information, including boxed WARNING and Medication Guide. CLINICAL RESULTS

9 AUBAGIO QUIETS RELAPSES * In all 3 clinical trials, AUBAGIO kept more patients relapse-free vs. placebo. CLINICAL TRIAL 1 on AUBAGIO 14 mg vs. 46% with placebo. 54% remained relapse-free on AUBAGIO 7 mg vs. 46% with placebo. Patient Portrayal AUBAGIO may stay in your blood for up to 2 years after you stop taking it. Your healthcare provider can prescribe a medicine that can remove AUBAGIO from your blood quickly. Please see Important Safety Information on pages 30 and 31 and accompanying full Prescribing Information, including boxed WARNING and Medication Guide. *AUBAGIO is effective against annualized relapse rates. Overall discontinuation rates due to adverse events were 12.5% with AUBAGIO 14 mg, 11.2% with AUBAGIO 7 mg, and 7.5% with placebo, and discontinuation rates due to common adverse events were 3.3% in the pooled clinical trials. CLINICAL RESULTS

10 If you are concerned about relapses, ask your healthcare provider if once-daily AUBAGIO may be right for you. CLINICAL TRIAL 2 CLINICAL TRIAL 3 on AUBAGIO 14 mg vs. 47% with placebo. 58% remained relapse-free on AUBAGIO 7 mg vs. 47% with placebo. on AUBAGIO 14 mg vs. 62% with placebo. 71% remained relapse-free on AUBAGIO 7 mg vs. 62% with placebo. Before taking AUBAGIO, talk with your healthcare provider if you have: liver or kidney problems; a fever or infection, or if you are unable to fight infections; numbness or tingling in your hands or feet that is different from your MS symptoms; diabetes; serious skin problems when taking other medicines; breathing problems; or high blood pressure. Your healthcare provider will check your blood cell count and TB test before you start AUBAGIO. Talk with your healthcare provider if you take or are planning to take other medicines (especially medicines for treating cancer or controlling your immune system), vitamins or herbal supplements. Please see Important Safety Information on pages 30 and 31 and accompanying full Prescribing Information, including boxed WARNING and Medication Guide. CLINICAL RESULTS

11 AUBAGIO QUIETS DISABILITY PROGRESSION * AUBAGIO 14 mg was shown to help keep patients free of disability progression. Patient Portrayal *AUBAGIO is effective against sustained disability progression (14 mg only). Overall discontinuation rates due to adverse events were 12.5% with AUBAGIO 14 mg, 11.2% with AUBAGIO 7 mg, and 7.5% with placebo, and discontinuation rates due to common adverse events were 3.3% in the pooled clinical trials. Doctors measure disability progression using a test called the Expanded Disability Status Scale, or EDSS. Your first score or your baseline will determine how your disability is gauged moving forward. If your baseline score is 5.5, you re considered to have sustained disability progression if that score goes up by one point (lasting at least 12 weeks). If your baseline score is >5.5, you re considered to have sustained disability progression if that score goes up by at least 0.5 point (lasting at least 12 weeks). AUBAGIO may cause serious side effects, including: reduced white blood cell count this may cause you to have more infections; numbness or tingling in your hands or feet that is different from your MS symptoms; allergic reactions, including serious skin problems; breathing problems (new or worsening); and high blood pressure. Patients with low white blood cell count should not receive certain vaccinations during AUBAGIO treatment and 6 months after. Tell your doctor if you have any side effect that bothers you or does not go away. Please see Important Safety Information on pages 30 and 31 and accompanying full Prescribing Information, including boxed WARNING and Medication Guide. CLINICAL RESULTS

12 Disability progression was looked at in 2 of the clinical trials. In both of those trials, AUBAGIO 14 mg was shown to help keep more people free from disability progression. AUBAGIO 7 mg did not achieve a statistically significant reduction in risk of sustained disability progression. CLINICAL TRIAL 1 CLINICAL TRIAL 2 80 % HAD NO DISABILITY PROGRESSION with AUBAGIO 14 mg vs. 73% with placebo. 78% remained free of disability progression with AUBAGIO 7 mg vs. 73% with placebo. 84 % HAD NO DISABILITY PROGRESSION with AUBAGIO 14 mg vs. 80% with placebo. 79% remained free of disability progression with AUBAGIO 7 mg vs. 80% with placebo. The most common side effects when taking AUBAGIO include: headache; diarrhea; nausea; hair thinning or loss; and abnormal liver test results. These are not all the side effects of AUBAGIO. Tell your healthcare provider about any side effect that bothers you. Please see Important Safety Information on pages 30 and 31 and accompanying full Prescribing Information, including boxed WARNING and Medication Guide. CLINICAL RESULTS

13 AUBAGIO QUIETS NEW LESIONS * One clinical trial looked at brain lesions as a key measure of disease activity. Patients taking AUBAGIO experienced less risk of new brain lesions vs. placebo. CLINICAL TRIAL 1 % FEWER NEW LESIONS with AUBAGIO 14 mg vs. placebo. 57% fewer new lesions with AUBAGIO 7 mg vs. placebo. Average lesions per scan *AUBAGIO is effective against MRI activity. Overall discontinuation rates due to adverse events were 12.5% with AUBAGIO 14 mg, 11.2% with AUBAGIO 7 mg, and 7.5% with placebo, and discontinuation rates due to common adverse events were 3.3% in the pooled clinical trials. Do not take AUBAGIO if you have severe liver problems, are pregnant or of childbearing potential and not using effective birth control, have had an allergic reaction to AUBAGIO or leflunomide, or are taking a medicine called leflunomide for rheumatoid arthritis. Please see Important Safety Information on pages 30 and 31 and accompanying full Prescribing Information, including boxed WARNING and Medication Guide. CLINICAL RESULTS

14 LEARN MORE WHAT YOU NEED TO KNOW TO HELP YOU DECIDE IF AUBAGIO IS RIGHT FOR YOU Patient Portrayal Patient Portrayal AUBAGIO may stay in your blood for up to 2 years after you stop taking it. Your healthcare provider can prescribe a medicine that can remove AUBAGIO from your blood quickly. Please see see Important Safety Safety Information Information on on pages pages 2830 and and 2931 and and accompanying accompanying full full Prescribing Prescribing Information, Information, including boxed including WARNING boxed WARNING and Medication and Medication Guide, enclosed. Guide. LEARN MORE

15 AUBAGIO IN THE BODY MS is thought to occur when immune cells become overactive and begin to attack the central nervous system, specifically targeting the outer covering of nerves known as the myelin sheath. While we don t know exactly how AUBAGIO works in relapsing MS, we do know that it works differently from other relapsing MS medicines. AUBAGIO is believed to block the enzyme needed for immune cells to keep multiplying at an overactive rate. When you have MS, certain immune cells in your body become overactive and multiply. AUBAGIO blocks an enzyme called DHODH that these overactive cells need to keep multiplying at their overactive rate. Taken daily, AUBAGIO reduces the number of overactive immune cells thought to cause MS flare-ups, while still allowing normal immune cell activity to occur. For illustrative purposes only. Before taking AUBAGIO, talk with your healthcare provider if you have: liver or kidney problems; a fever or infection, or if you are unable to fight infections; numbness or tingling in your hands or feet that is different from your MS symptoms; diabetes; serious skin problems when taking other medicines; breathing problems; or high blood pressure. Your healthcare provider will check your blood cell count and TB test before you start AUBAGIO. Talk with your healthcare provider if you take or are planning to take other medicines (especially medicines for treating cancer or controlling your immune system), vitamins or herbal supplements. Please see Important Safety Information on pages 30 and 31 and accompanying full Prescribing Information, including boxed WARNING and Medication Guide. Patient Portrayal LEARN MORE

16 ABOUT POTENTIAL SIDE EFFECTS POSSIBLE SERIOUS SIDE EFFECTS It s important to know the serious risks of any medication you take. And when it comes to AUBAGIO (teriflunomide), it s no different. If you experience any of the following side effects while taking AUBAGIO, speak with your healthcare provider right away. In addition to the risk of liver problems and the risk of harm to an unborn baby, other serious side effects include: Reduced white blood cell count this may cause you to have more infections Numbness or tingling in your hands or feet that is different from your MS symptoms Allergic reactions, including serious skin problems Breathing problems (new or worsening) High blood pressure Certain vaccinations should be avoided during treatment with AUBAGIO and for at least 6 months after discontinuation MOST COMMON SIDE EFFECTS Here are some of the most common side effects reported in the clinical trials. These are not all the side effects. SIDE EFFECTS Headache Abnormal liver test results Diarrhea Hair thinning or loss Nausea AUBAGIO 14 mg (n=1002) 7 mg (n=1045) 16% 15% 14% 13% 11% 18% 13% 13% 10% 8% Tell your doctor if you have any side effect that bothers you or does not go away. Please see Important Safety Information on pages 30 and 31 and accompanying full Prescribing Information, including boxed WARNING and Medication Guide. PLACEBO (n=997) 15% 9% 8% 5% 7% n=number of people in trial LEARN MORE

17 SEE HOW MANY PEOPLE STOPPED TAKING AUBAGIO DUE TO COMMON SIDE EFFECTS, IN CLINICAL TRIALS DISCONTINUATION RATES DUE TO COMMON SIDE EFFECTS SIDE EFFECTS AUBAGIO 14 mg (n=1002) 7 mg (n=1045) PLACEBO (n=997) Diarrhea 0.4% 0.5% 0.1% Nausea 0.3% 0.1% 0% Hair thinning or loss 1.3% 0.2% 0.1% Abnormal liver test results 2.6% 3.3% 2.3% Headache 0% 0% 0.3% n=number of people in trial Please see Important Safety Information on pages 30 and 31 and accompanying full Prescribing Information, including boxed WARNING and Medication Guide. LEARN MORE

18 3 QUESTIONS COVER A LOT Start the conversation about relapsing MS treatment and AUBAGIO (teriflunomide) with your healthcare provider. Just ask: 1 How well do current relapsing MS medications work? 2 What should I know about the side effects of each option? 3 Which treatment is right for me? ASK IF AUBAGIO IS RIGHT FOR YOU Patient Portrayal AUBAGIO may cause serious side effects, including: reduced white blood cell count this may cause you to have more infections; numbness or tingling in your hands or feet that is different from your MS symptoms; allergic reactions, including serious skin problems; breathing problems (new or worsening); and high blood pressure. Patients with low white blood cell count should not receive certain vaccinations during AUBAGIO treatment and 6 months after. Tell your doctor if you have any side effect that bothers you or does not go away. Please see Important Safety Information on pages 30 and 31 and accompanying full Prescribing Information, including boxed WARNING and Medication Guide. LEARN MORE

19 CHECK OUT A LIVE EVENT The maker of AUBAGIO (teriflunomide) hosts free special events all across the country for people living with relapsing MS and their care partners. You ll hear from an MS expert and others living with relapsing MS. Whether you re on AUBAGIO or considering it, please join us. Signing up for an event is an easy way to learn about relapsing MS. Simply go to aubagioevents.com to find an event near you. The most common side effects when taking AUBAGIO include: headache; diarrhea; nausea; hair thinning or loss; and abnormal liver test results. These are not all the side effects of AUBAGIO. Tell your healthcare provider about any side effect that bothers you. Please see Important Safety Information on pages 30 and 31 and accompanying full Prescribing Information, including boxed WARNING and Medication Guide. LEARN MORE

20 $0 CO-PAY PROGRAM To learn more about how eligible patients with commercial insurance can become part of the $0 Co-Pay Program* and about other ways that may help pay for AUBAGIO (teriflunomide), click here. *Out-of-pocket costs related to medical appointments, evaluations, testing, or other related services are not covered by the AUBAGIO Co-Pay Program. Patient Portrayal Please see Important Safety Information on pages 30 and 31 and accompanying full Prescribing Information, including boxed WARNING and Medication Guide. LEARN MORE

21 GETTING STARTED WHAT YOU NEED TO KNOW TO BEGIN ONCE-DAILY AUBAGIO Do not take AUBAGIO if you have severe liver problems, are pregnant or of childbearing potential and not using effective birth control, have had an allergic reaction to AUBAGIO or leflunomide, or are taking a medicine called leflunomide for rheumatoid arthritis. Please see Important Safety Information on pages 30 and 31 and accompanying full Prescribing Information, including boxed WARNING and Medication Guide. G E T T I N G S TA R T E D Patient Portrayal

22 TODAY IS A NEW BEGINNING You re about to start AUBAGIO (teriflunomide). This brochure will walk you through the basics of beginning AUBAGIO, including details about: Tests you ll need 24-hour personalized support Financial assistance G E T T I N G S TA R T E D Please see Important Safety Information on pages 30 and 31 and accompanying full Prescribing Information, including boxed WARNING and Medication Guide.

23 First things first Before you start on AUBAGIO (teriflunomide), your healthcare provider will need to run a few tests within 6 months before beginning treatment. Your healthcare provider will check for the following, but these are often done together: Perform blood tests to check your liver Perform a TB (tuberculosis) skin test or blood test for mycobacterium tuberculosis infection Perform a pregnancy test, if you are a woman of childbearing potential Obtain a complete blood count Check your blood pressure G E T T I N G S TA R T E D Patient Portrayal Please see Important Safety Information on pages 30 and 31 and accompanying full Prescribing Information, including boxed WARNING and Medication Guide.

24 GET SUPPORT THAT S TRULY PERSONAL Once you begin taking AUBAGIO (teriflunomide), you ll have access to the following MS One to One offerings: Your own dedicated Nurse, who will get to know you and is available Monday Friday, 8:30 AM to 8:00 PM ET which means you won t have to start over with your story each time you call Your Nurse s direct extension, so you can reach out with questions or concerns, or simply talk Assistance navigating your insurance, including benefits verification and financial assistance for eligible patients. Help connecting with financial assistance programs that have a specialty pharmacy Visit aubagio.com to learn more. Patient Portrayal G E T T I N G S TA R T E D Please see Important Safety Information on pages 30 and 31 and accompanying full Prescribing Information, including boxed WARNING and Medication Guide.

25 When I started AUBAGIO (teriflunomide), I got the monthly phone call from MS One to One to remind me to have my routine blood work, and just to check in to see how I was doing. Heather On AUBAGIO 14 mg Individual experiences may vary G E T T I N G S TA R T E D Please see Important Safety Information on pages 30 and 31 and accompanying full Prescribing Information, including boxed WARNING and Medication Guide.

26 $0 CO-PAY NOTHING S LOWER The last thing you want to worry about is paying for your medication. That s why the AUBAGIO (teriflunomide) Co-Pay Program offers assistance for those with commercial insurance. It assists with drug-related out-of-pocket expenses including co-pays and co-insurance regardless of your financial status. Once enrolled in the program, you ll have a $0 co-payment.* ADDITIONAL FINANCIAL ASSISTANCE If you do not have insurance or are unable to pay for treatment, the Sanofi Genzyme Patient Assistance Program could be the answer. Another solution: an MS One to One Nurse may be able to direct you to not-for-profit organizations that may be able to provide support. Talk to an MS One to One Nurse for more information and to ask for help from any of these programs. You may also want to check with your local patient advocacy group about other support. *Out-of-pocket costs related to medical appointments, evaluations, testing, or other related services are not covered by the AUBAGIO Co-Pay Program. G E T T I N G S TA R T E D Please see Important Safety Information on pages 30 and 31 and accompanying full Prescribing Information, including boxed WARNING and Medication Guide.

27 Call MS One to One at , or visit aubagio.com to learn more. We re Here to Help G E T T I N G S TA R T E D Patient Portrayal Please see Important Safety Information on pages 30 and 31 and accompanying full Prescribing Information, including boxed WARNING and Medication Guide.

28 HELPFUL RESOURCES American Academy of Neurology (AAN) aan.com Dedicated to helping people understand neurology and the available treatments for neurological disorders, including MS. Multiple Sclerosis Foundation (MSF) msfocus.org MSF offers a wide range of free services, including national toll-free support, home care, support groups, assistive technology, and more. National Multiple Sclerosis Society nationalmssociety.org A 50-state U.S. network that helps people with the challenges of MS. Please see Important Safety Information on pages 30 and 31 and accompanying full Prescribing Information, including boxed WARNING and Medication Guide. G E T T I N G S TA R T E D MS One to One msonetoone.com Start a one-on-one conversation with an MS One to One Nurse who understands MS and what you re going through.

29 MSWorld msworld.org Provides online support, chat, and message boards to more than 150,000 worldwide living with MS. MyMSTeam mymsteam.com A social network for those living with MS. Turn to them for practical advice and insights on managing life with MS. Multiple Sclerosis Association of America (MSAA) mymsaa.org A national organization dedicated to improving the quality of life for everyone affected by MS. Caregiver Action Network caregiveraction.org Educates, supports, and empowers people who take care of loved ones who have chronic illnesses or disabilities. G E T T I N G S TA R T E D Please see Important Safety Information on pages 30 and 31 and accompanying full Prescribing Information, including boxed WARNING and Medication Guide. Can Do Multiple Sclerosis mscando.org Lifestyle empowerment programs for people with MS.

30 INDICATION AND IMPORTANT SAFETY INFORMATION INDICATION AUBAGIO (teriflunomide) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS). IMPORTANT SAFETY INFORMATION DO NOT TAKE AUBAGIO IF YOU: Have severe liver problems. AUBAGIO may cause serious liver problems, which can be life-threatening. Your risk may be higher if you take other medicines that affect your liver. Your healthcare provider should do blood tests to check your liver within 6 months before you start AUBAGIO and monthly for 6 months after starting AUBAGIO. Tell your healthcare provider right away if you develop any of these symptoms of liver problems: nausea, vomiting, stomach pain, loss of appetite, tiredness, yellowing of your skin or whites of your eyes, or dark urine. Are pregnant. AUBAGIO may harm an unborn baby. You should have a pregnancy test before starting AUBAGIO. After stopping AUBAGIO, continue to use effective birth control until you have made sure your blood levels of AUBAGIO are lowered. If you become pregnant while taking AUBAGIO or within 2 years after stopping, tell your healthcare provider right away and enroll in the AUBAGIO Pregnancy Registry at , option 2. Are of childbearing potential and not using effective birth control. It is not known if AUBAGIO passes into breast milk. Your healthcare provider can help you decide if you should take AUBAGIO or breastfeed you should not do both at the same time. If you are a man whose partner plans to become pregnant, you should stop taking AUBAGIO and talk with your healthcare provider about reducing the levels of AUBAGIO in your blood. If your partner does not plan to become pregnant, use effective birth control while taking AUBAGIO. Have had an allergic reaction to AUBAGIO or a medicine called leflunomide. Take a medicine called leflunomide for rheumatoid arthritis. AUBAGIO may stay in your blood for up to 2 years after you stop taking it. Your healthcare provider can prescribe a medicine that can remove AUBAGIO from your blood quickly. IMPORTANT SAFETY INFORMATION

31 IMPORTANT SAFETY INFORMATION (continued) Before taking AUBAGIO, talk with your healthcare provider if you have: liver or kidney problems; a fever or infection, or if you are unable to fight infections; numbness or tingling in your hands or feet that is different from your MS symptoms; diabetes; serious skin problems when taking other medicines; breathing problems; or high blood pressure. Your healthcare provider will check your blood cell count and TB test before you start AUBAGIO. Talk with your healthcare provider if you take or are planning to take other medicines (especially medicines for treating cancer or controlling your immune system), vitamins or herbal supplements. AUBAGIO may cause serious side effects, including: reduced white blood cell count this may cause you to have more infections; numbness or tingling in your hands or feet that is different from your MS symptoms; allergic reactions, including serious skin problems; breathing problems (new or worsening); and high blood pressure. Patients with low white blood cell count should not receive certain vaccinations during AUBAGIO treatment and 6 months after. Tell your doctor if you have any side effect that bothers you or does not go away. The most common side effects when taking AUBAGIO include: headache; diarrhea; nausea; hair thinning or loss; and abnormal liver test results. These are not all the side effects of AUBAGIO. Tell your healthcare provider about any side effect that bothers you. Consult your healthcare provider if you have questions about your health or any medications you may be taking, including AUBAGIO. You are encouraged to report side effects of prescription drugs to the FDA. Visit or call FDA Please see full Prescribing Information, including boxed WARNING and Medication Guide, enclosed. IMPORTANT SAFETY INFORMATION

32 2017 Genzyme Corporation. All rights reserved. AUBAGIO, MS One to One, Sanofi and Genzyme registered in U.S. Patent and Trademark Office. SAUS.AUBA July Please see Important Safety Information on pages 30 and 31 of this brochure and accompanying full Prescribing Information, including boxed WARNING and Medication Guide, enclosed.

One daily pill can help prevent HIV. TRUVADA for PrEP, together with safer sex practices, can mean better protection.

One daily pill can help prevent HIV. TRUVADA for PrEP, together with safer sex practices, can mean better protection. TRUVADA for PrEP is a prescription medicine that can help reduce the risk of getting HIV-1 through sex, when taken every day and used together with safer sex practices. TRUVADA for PrEP is only for people

More information

KEEP LOVING. Because HIV doesn t change who you are.

KEEP LOVING. Because HIV doesn t change who you are. KEEP LOVING. Because HIV doesn t change who you are. BIKTARVY is a complete, 1-pill, once-a-day prescription medicine used to treat HIV-1 in certain adults. BIKTARVY does not cure HIV-1 or AIDS. Please

More information

A GUIDE TO STARTING TREATMENT

A GUIDE TO STARTING TREATMENT A GUIDE TO STARTING TREATMENT Please see accompanying and Medication Guide. full Prescribing IDHIFA (enasidenib) is a prescription medicine used to treat people with acute myeloid leukemia (AML) with an

More information

MS Treatments Aubagio TM

MS Treatments Aubagio TM 1 MSology Essentials Series Aubagio TM (teriflunomide) Developed by MSology with the invaluable assistance of multiple sclerosis nurse advisors: Bonnie Blain Central Alberta MS Clinic, Red Deer, Alberta

More information

Have a healthy discussion. Use this guide to start a. conversation. with your. healthcare provider

Have a healthy discussion. Use this guide to start a. conversation. with your. healthcare provider Have a healthy discussion Use this guide to start a conversation with your healthcare provider MAKE THE CONVERSATION COUNT Here are some things you may want to reflect on and discuss with your healthcare

More information

SAY HELLO TO CLEARER SKIN. SAY HELLO TO TREMFYA.

SAY HELLO TO CLEARER SKIN. SAY HELLO TO TREMFYA. FOR PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS SAY HELLO TO CLEARER SKIN. SAY HELLO TO TREMFYA. INDIVIDUAL RESULTS MAY VARY TREMFYA is a prescription medicine used to treat adults with moderate

More information

Take on IPF progression with OFEV

Take on IPF progression with OFEV Every breath matters Take on IPF progression with OFEV Learn more at www.ofev.com IPF=idiopathic pulmonary fibrosis. Please see throughout Understand how IPF affects you Idiopathic pulmonary fibrosis (IPF)

More information

EMBRACING TODAY TOGETHER. A Guide For Caregivers

EMBRACING TODAY TOGETHER. A Guide For Caregivers EMBRACING TODAY TOGETHER A Guide For Caregivers IBRANCE is a prescription medicine that is used along with the medicine letrozole for the treatment of postmenopausal women with estrogen receptor (ER)-positive,

More information

You matter and so does your health.

You matter and so does your health. DESCOVY is a prescription medicine that is used together with other HIV-1 medicines to treat HIV-1 in people who weigh at least 77 lbs (35kg). DESCOVY does not cure HIV-1 or AIDS. Do not use DESCOVY to

More information

How are unresolved Myasthenia Gravis symptoms disrupting your day? Talk to your doctor about your symptoms

How are unresolved Myasthenia Gravis symptoms disrupting your day? Talk to your doctor about your symptoms How are unresolved Myasthenia Gravis symptoms disrupting your day? Talk to your doctor about your symptoms Recognize the symptoms of your generalized Myasthenia Gravis (gmg) Anti-acetylcholine receptor

More information

YOUR GUIDE TO PATIENT SUPPORT SERVICES

YOUR GUIDE TO PATIENT SUPPORT SERVICES YOUR GUIDE TO PATIENT SUPPORT SERVICES Please see Important Safety Information About ONIVYDE (irinotecan liposome injection) on pages 6 7. WHAT IS PROVYDE (ONIVYDE ACCESS SERVICES)? PROVYDE is a team of

More information

Your guide to taking LENVIMA for hepatocellular carcinoma (HCC), a type of liver cancer

Your guide to taking LENVIMA for hepatocellular carcinoma (HCC), a type of liver cancer Your guide to taking LENVIMA for hepatocellular carcinoma (HCC), a type of liver cancer LENVIMA is a prescription medicine that is used by itself as the first treatment for a type of liver cancer called

More information

Getting started on Otezla

Getting started on Otezla Getting started on Otezla Your guide to starting and staying on treatment Otezla (apremilast) is a prescription medicine approved for the treatment of patients with moderate to severe plaque psoriasis

More information

READY. SET. DOPTELET. HELP GET READY FOR YOUR UPCOMING PROCEDURE

READY. SET. DOPTELET. HELP GET READY FOR YOUR UPCOMING PROCEDURE HELP GET READY FOR YOUR UPCOMING PROCEDURE READY. SET. DOPTELET. Full Prescribing Information for DOPTELET (avatrombopag), including Patient For adults with chronic liver disease and a low platelet count

More information

Talking about your treatment. A guide to the conversations you may have before starting LEMTRADA

Talking about your treatment. A guide to the conversations you may have before starting LEMTRADA Talking about your treatment A guide to the conversations you may have before starting LEMTRADA INTRODUCTION HEALTHCARE TEAM CARE TEAM COWORKERS Please see Important Safety Information on pages 6-7 and

More information

DEDICATED SUPPORT TO HELP YOU GET STARTED AND STAY ON TRACK THROUGHOUT YOUR TREATMENT

DEDICATED SUPPORT TO HELP YOU GET STARTED AND STAY ON TRACK THROUGHOUT YOUR TREATMENT LET US HELP YOU FIND A CLEARER PATH FORWARD. DEDICATED SUPPORT TO HELP YOU GET STARTED AND STAY ON TRACK THROUGHOUT YOUR TREATMENT PERSONALIZED SUPPORT FREE MEDICATION* $0 CO-PAY* WELCOME KIT RECYCLABLE

More information

Starting KAZANO gave me MORE POWER than metformin alone, with 2 medicines in 1 tablet

Starting KAZANO gave me MORE POWER than metformin alone, with 2 medicines in 1 tablet For many adults with type 2 diabetes Starting KAZANO gave me MORE POWER than metformin alone, with 2 medicines in 1 tablet Individual results may vary. Not actual patient. KAZANO is a prescription medicine

More information

BLINCYTO can eliminate detectable traces of cancer 1

BLINCYTO can eliminate detectable traces of cancer 1 For people* with B-cell precursor ALL who are MRD+, 1 BLINCYTO can eliminate detectable traces of cancer 1 In a study of 86 adults with MRD+ B-cell precursor ALL, BLINCYTO removed detectable traces of

More information

A GUIDE TO TREATMENT WHILE TAKING RYDAPT FOR ADVANCED SM

A GUIDE TO TREATMENT WHILE TAKING RYDAPT FOR ADVANCED SM For patients with 3 types of systemic mastocytosis (SM)* * Aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), and mast cell leukemia (MCL) are

More information

AN ADVANCEMENT FOR POSTMENOPAUSAL WOMEN WITH ER+/HER2- METASTATIC BREAST CANCER.

AN ADVANCEMENT FOR POSTMENOPAUSAL WOMEN WITH ER+/HER2- METASTATIC BREAST CANCER. For estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer. AN ADVANCEMENT FOR POSTMENOPAUSAL WOMEN WITH ER+/HER2- METASTATIC BREAST CANCER.

More information

Discussing TECENTRIQ (atezolizumab) with your healthcare team Talking to Your Doctor

Discussing TECENTRIQ (atezolizumab) with your healthcare team Talking to Your Doctor Discussing TECENTRIQ (atezolizumab) with your healthcare team Talking to Your Doctor TECENTRIQ DISCUSSION SUPPORT What is TECENTRIQ? TECENTRIQ is a prescription medicine used to treat: A type of bladder

More information

Randy J. EMPLICITI patient Ready to get started

Randy J. EMPLICITI patient Ready to get started Randy J. EMPLICITI patient Ready to get started PICTURE YOUR IMMUNE SYSTEM AT WORK AGAINST MULTIPLE MYELOMA Randy J. EMPLICITI patient My body taking on multiple myeloma What is EMPLICITI? EMPLICITI is

More information

was proven to help people live longer1 BLINCYTO A guide for patients and caregivers

was proven to help people live longer1 BLINCYTO A guide for patients and caregivers In a clinical trial for people with a certain kind of ALL whose cancer has returned or didn t respond to treatment 1 BLINCYTO was proven to help people live longer1 In a study of 405 adults with ALL, 271

More information

offers the possibility of a longer life 1 BLINCYTO A guide for patients and caregivers

offers the possibility of a longer life 1 BLINCYTO A guide for patients and caregivers In a study of 405 adults with Philadelphia chromosome negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia, 271 were treated with BLINCYTO and 134 with chemotherapy. The adults

More information

What are my treatment support resources?

What are my treatment support resources? What are my treatment support resources? Get help when you need it. Click here for full Prescribing Information including risk of SERIOUS SIDE EFFECTS and Medication Guide. We re here to help you......

More information

YOUR CABOMETYX HANDBOOK

YOUR CABOMETYX HANDBOOK YOUR CABOMETYX HANDBOOK AN OVERVIEW FOR PATIENTS AND CAREGIVERS in the full Prescribing Information. Table of Contents What s included in this handbook... 3 A kidney cancer overview...4 About CABOMETYX...4

More information

TIPS FOR GETTING THE MOST OUT OF YOUR TREATMENT.

TIPS FOR GETTING THE MOST OUT OF YOUR TREATMENT. Keeping it Real. TIPS FOR GETTING THE MOST OUT OF YOUR TREATMENT. Guiding you through your treatment Taking KISQALI (ribociclib) as prescribed is essential to getting the most out of your treatment. That

More information

Fuel your determination to live longer with KYPROLIS. Look inside to learn more.

Fuel your determination to live longer with KYPROLIS. Look inside to learn more. F O R R E L A P S E D MULT IP L E M Y E L OM A APPROVED USES KYPROLIS is a prescription medication used to treat patients with relapsed or refractory multiple myeloma who have received one to three previous

More information

UNDERSTANDING POLYCYTHEMIA VERA (PV) A guide for patients and caregivers

UNDERSTANDING POLYCYTHEMIA VERA (PV) A guide for patients and caregivers UNDERSTANDING POLYCYTHEMIA VERA (PV) A guide for patients and caregivers Jakafi is used to treat adults with polycythemia vera who have already taken a medicine called hydroxyurea and it did not work well

More information

She is scared sometimes, and so am I, but who wouldn t be? I am proud that we have never given up and never lost hope.

She is scared sometimes, and so am I, but who wouldn t be? I am proud that we have never given up and never lost hope. Taking Care A Guide For Caregivers Being The Face Of Support As a caregiver for someone living with metastatic breast cancer, your role is absolutely vital. There may be no cure for the disease, but with

More information

PATIENT SAFETY BROCHURE; IMPORTANT SAFETY INFORMATION FOR PATIENTS. Before starting on Soliris Important safety information for patients

PATIENT SAFETY BROCHURE; IMPORTANT SAFETY INFORMATION FOR PATIENTS. Before starting on Soliris Important safety information for patients PATIENT SAFETY BROCHURE; IMPORTANT SAFETY INFORMATION FOR PATIENTS Before starting on Soliris Important safety information for patients Before you begin Soliris (eculizumab) treatment, your physician will

More information

Rick N. EMPLICITI patient Ready to get started

Rick N. EMPLICITI patient Ready to get started Rick N. EMPLICITI patient Ready to get started PICTURE YOUR IMMUNE SYSTEM AT WORK AGAINST MULTIPLE MYELOMA Rick N. EMPLICITI patient My body taking on multiple myeloma What is EMPLICITI? EMPLICITI is a

More information

Life shouldn't take a back seat to plaque psoriasis.

Life shouldn't take a back seat to plaque psoriasis. Life shouldn't take a back seat to plaque psoriasis. Journey toward clearer skin with SILIQ. Ask your healthcare provider if SILIQ is an option for you. What is SILIQ? SILIQ injection is a prescription

More information

PATIENT GUIDE. Highlights of Important Safety Information Warnings and Precautions. Your guide to treatment with Signifor LAR for acromegaly

PATIENT GUIDE. Highlights of Important Safety Information Warnings and Precautions. Your guide to treatment with Signifor LAR for acromegaly PATIENT GUIDE Your guide to treatment with Signifor LAR for acromegaly Signifor LAR is indicated for the treatment of patients with acromegaly for whom surgery has not worked well enough or who cannot

More information

How does my new treatment work?

How does my new treatment work? How does my new treatment work? Get to know KEVZARA better. Click here for full Prescribing Information including 1 risk of SERIOUS SIDE EFFECTS and Medication Guide. You're starting KEVZARA... GOT A QUESTION?

More information

FAMILY PLANNING AND AUBAGIO (teriflunomide)

FAMILY PLANNING AND AUBAGIO (teriflunomide) FAMILY PLANNING AND AUBAGIO (teriflunomide) INDICATION AUBAGIO (teriflunomide) is indicated for the treatment of patients with relapsing forms of multiple sclerosis. IMPORTANT SAFETY INFORMATION WARNING:

More information

MEDICATION GUIDE. (belatacept) For Injection, For Intravenous Use

MEDICATION GUIDE. (belatacept) For Injection, For Intravenous Use MEDICATION GUIDE NULOJIX (noo-loj-jiks) (belatacept) For Injection, For Intravenous Use Read this Medication Guide before you start receiving NULOJIX and before each treatment. There may be new information.

More information

Medication Guide Enbrel (en-brel) (etanercept)

Medication Guide Enbrel (en-brel) (etanercept) Medication Guide Enbrel (en-brel) (etanercept) Read the Medication Guide that comes with Enbrel before you start using it and each time you get a refill. There may be new information. This Medication Guide

More information

UNDERSTANDING MYELOFIBROSIS (MF) A guide for patients and caregivers

UNDERSTANDING MYELOFIBROSIS (MF) A guide for patients and caregivers UNDERSTANDING MYELOFIBROSIS (MF) A guide for patients and caregivers Jakafi is used to treat adults with intermediate or high-risk myelofibrosis (MF), including primary MF, post polycythemia vera MF and

More information

GAZYVA for Chronic Lymphocytic Leukemia (CLL)

GAZYVA for Chronic Lymphocytic Leukemia (CLL) GAZYVA for Chronic Lymphocytic Leukemia (CLL) GAZYVA is a prescription medicine used with the chemotherapy drug, chlorambucil, to treat chronic lymphocytic leukemia (CLL) in adults who have not had previous

More information

Discover CRYSVITA and Redefine XLH TREATMENT

Discover CRYSVITA and Redefine XLH TREATMENT Discover CRYSVITA and Redefine XLH TREATMENT CRYSVITA is a prescription medicine used to treat adults and children 1 year of age and older with X-linked hypophosphatemia (XLH). 10 mg/ml, 20 mg/ml, 30 mg/ml

More information

Tips to Help Treat Diarrhea, Nausea, and Vomiting Side Effects

Tips to Help Treat Diarrhea, Nausea, and Vomiting Side Effects Tips to Help Treat Diarrhea, Nausea, and Vomiting Side Effects If you have been prescribed OFEV (nintedanib) capsules for the treatment of idiopathic pulmonary fibrosis (IPF) this brochure can help you

More information

LIVING PROOF. 23% Reduction in the risk of death compared with standardof-care. A guide to combination treatment with RYDAPT

LIVING PROOF. 23% Reduction in the risk of death compared with standardof-care. A guide to combination treatment with RYDAPT My LIVING PROOF THAT TREATING NEWLY DIAGNOSED FLT3-POSITIVE AML HAS CHANGED 23% Reduction in the risk of death compared with standardof-care chemotherapy alone A specific median overall survival (the time

More information

KEEP UP THE FIGHT WITH. Little Victories

KEEP UP THE FIGHT WITH. Little Victories FOR MODERATE TO SEVERE RHEUMATOID ARTHRITIS (RA) KEEP UP THE FIGHT WITH Little Victories Small improvements in your daily activities may be a sign that ORENCIA (abatacept) is working for you. Use this

More information

If you wake up to urinate 2 or more times a night, ask your doctor about NOCTIVA

If you wake up to urinate 2 or more times a night, ask your doctor about NOCTIVA If you wake up to urinate 2 or more times a night, ask your doctor about NOCTIVA IMPORTANT SAFETY INFORMATION WARNING: HYPONATREMIA See full prescribing information for complete boxed warning. NOCTIVA

More information

Take the next step with Strensiq.

Take the next step with Strensiq. Introducing Strensiq : the first and only treatment for people with perinatal/infantile- and juvenile-onset hypophosphatasia (HPP) Take the next step with Strensiq. Strensiq can improve bone health in

More information

PEOPLE ARE TAKING WORKS FOR THEM. Ask your healthcare provider if it could work for you, too. a medication that

PEOPLE ARE TAKING WORKS FOR THEM. Ask your healthcare provider if it could work for you, too. a medication that 5 PEOPLE ARE TAKING a medication that WORKS FOR THEM. Ask your healthcare provider if it could work for you, too. Could TRIUMEQ be an HIV-1 treatment for you to move forward with? Whether you re considering

More information

Before starting on Soliris.

Before starting on Soliris. Before starting on Soliris. Important safety information for patients Before you begin Soliris (eculizumab) treatment, your physician will give you a: Medication Guide Soliris Patient Safety Information

More information

MEDICATION GUIDE. Peganone 250 mg Tablets (PEG-ah-noan) (ethotoin tablets, USP)

MEDICATION GUIDE. Peganone 250 mg Tablets (PEG-ah-noan) (ethotoin tablets, USP) MEDICATION GUIDE Peganone 250 mg Tablets (PEG-ah-noan) (ethotoin tablets, USP) Read this Medication Guide before you start taking PEGANONE and each time you get a refill. There may be new information.

More information

Medication Tracker for ZYTIGA (abiraterone acetate)

Medication Tracker for ZYTIGA (abiraterone acetate) Medication Tracker for YTIGA (abiraterone acetate) See the next page to help set up a medication schedule that works for you, as directed by your doctor. Write in the administration times that suit you

More information

Doctor Discussion Guide

Doctor Discussion Guide Talking to your healthcare provider about LONSURF (trifluridine and tipiracil) tablets If you have colon or rectal cancer that has spread to other parts of your body and have previously been treated with

More information

Inlyta (axitinib) for Kidney Cancer

Inlyta (axitinib) for Kidney Cancer Inlyta (axitinib) for Kidney Cancer Inlyta is a medication used to treat advanced kidney cancer in adults when one prior drug treatment for this disease has not worked Dosage: 5mg taken twice a day How

More information

severe diarrhea? Do you have ZINPLAVA is a medicine that helps reduce the risk that your C diff will come back.

severe diarrhea? Do you have ZINPLAVA is a medicine that helps reduce the risk that your C diff will come back. Do you have severe diarrhea? It could be a potentially serious infection known as C diff, caused by the bacteria Clostridium difficile. In some people, C diff can come back. Not an actual patient. ZINPLAVA

More information

PRESCRIBER SAFETY BROCHURE; IMPORTANT SAFETY INFORMATION FOR THE HEALTHCARE PROVIDER

PRESCRIBER SAFETY BROCHURE; IMPORTANT SAFETY INFORMATION FOR THE HEALTHCARE PROVIDER PRESCRIBER SAFETY BROCHURE; IMPORTANT SAFETY INFORMATION FOR THE HEALTHCARE PROVIDER BEFORE STARTING YOUR PATIENTS ON SOLIRIS Important safety information for the healthcare provider Prior to initiating

More information

A GUIDE TO TALKING WITH YOUR DOCTOR ABOUT EPIDIOLEX

A GUIDE TO TALKING WITH YOUR DOCTOR ABOUT EPIDIOLEX A GUIDE TO TALKING WITH YOUR DOCTOR ABOUT EPIDIOLEX You are encouraged to have an open conversation with your doctor about your treatment goals and current medicines. It is important in determining if

More information

People who have received 1-3 prior treatments for their multiple myeloma may receive: Revlimid (lenalidomide)

People who have received 1-3 prior treatments for their multiple myeloma may receive: Revlimid (lenalidomide) FINDTHE THE FIND STRENGTH STRENGTH WITHIN WITHIN TOHELP HELPFIGHT FIGHT TO MULTIPLEMYELOMA MYELOMA MULTIPLE Rick N. N. patient Rick patient What is? is a prescription medicine used with other medications

More information

Giving appropriate patients another chance to fight OPDIVO

Giving appropriate patients another chance to fight OPDIVO For dmmr/msi-h Colorectal Cancer (CRC) All individuals depicted are models used for illustrative purposes only. Who is OPDIVO for? OPDIVO is a prescription medicine used to treat colorectal cancer (a type

More information

JUST FOR KIDS SELECTED IMPORTANT SAFETY INFORMATION

JUST FOR KIDS SELECTED IMPORTANT SAFETY INFORMATION JUST FOR KIDS For children ages 6-17 with moderately to severely active Crohn s disease or ulcerative colitis (UC) who haven t responded well to other therapies SELECTED IMPORTANT SAFETY INFORMATION REMICADE

More information

GAZYVA: for follicular lymphoma that has not responded to or has returned after treatment

GAZYVA: for follicular lymphoma that has not responded to or has returned after treatment GAZYVA: for follicular lymphoma that has not responded to or has returned after treatment GAZYVA is a prescription medicine used with the chemotherapy drug, bendamustine, followed by GAZYVA alone for follicular

More information

Indication. Important Safety Information

Indication. Important Safety Information When symptoms of a hereditary angioedema (HAE) attack appear Reach for FIRAZYR first Self-administer FIRAZYR (icatibant injection) upon recognition of an HAE attack after you have been trained by a healthcare

More information

Does yours? Most school-age kids with asthma have allergic asthma. Enroll in our support program. Learn about this distinct condition

Does yours? Most school-age kids with asthma have allergic asthma. Enroll in our support program. Learn about this distinct condition Most school-age kids with asthma have allergic asthma. Does yours? Learn about this distinct condition Enroll in our support program for tools, information on financial resources, and more at GetSupportForYou.com

More information

Treatment Journal. Therapy Tracker TREATMENT JOURNAL

Treatment Journal. Therapy Tracker TREATMENT JOURNAL TREATMENT JOURNAL Treatment Journal & Therapy Tracker Please see full Prescribing Information, including Boxed WARNING and Medication Guide, for FARYDAK (panobinostat) capsules. This journal can help you:

More information

WE RE IN A CONSTANT STRUGGLE. BUT WITH AFINITOR, WE VE FOUND ANOTHER OPTION.

WE RE IN A CONSTANT STRUGGLE. BUT WITH AFINITOR, WE VE FOUND ANOTHER OPTION. SEGA TSC Novartis Pharmaceuticals Corporation is committed to supporting individuals affected by SEGA with TSC through therapeutic innovation, patient assistance, and support of advocacy organizations.

More information

MEDICATION GUIDE PegIntron (peg-in-tron) (Peginterferon alfa-2b) for injection, for subcutaneous use

MEDICATION GUIDE PegIntron (peg-in-tron) (Peginterferon alfa-2b) for injection, for subcutaneous use MEDICATION GUIDE PegIntron (peg-in-tron) (Peginterferon alfa-2b) for injection, for subcutaneous use If you are taking PegIntron with REBETOL (ribavirin) with or without an approved hepatitis C virus (HCV)

More information

How SYLVANT May Help IMPORTANT SAFETY INFORMATION. Multicentric Castleman s Disease.

How SYLVANT May Help IMPORTANT SAFETY INFORMATION. Multicentric Castleman s Disease. SYLVANT (siltuximab) is a prescription medicine used to treat people with Multicentric Castleman s Disease (MCD) who do not have human immunodeficiency virus (HIV) and human herpesvirus-8 (HHV-8) infection.

More information

Discover the facts about

Discover the facts about Avastin is approved to treat metastatic colorectal cancer (mcrc) for: First- or second-line treatment in combination with intravenous 5-fluorouracil based chemotherapy Second-line treatment when used with

More information

3 generations of ADPKD. 1 long-awaited treatment.

3 generations of ADPKD. 1 long-awaited treatment. 3 generations of ADPKD. 1 long-awaited treatment. HOPE is finally here now that treatment is available for people with autosomal dominant polycystic kidney disease (ADPKD). JYNARQUE is proven to slow kidney

More information

What You Need to Know About LEMTRADA (alemtuzumab) Treatment: A Patient Guide

What You Need to Know About LEMTRADA (alemtuzumab) Treatment: A Patient Guide For Patients What You Need to Know About LEMTRADA (alemtuzumab) Treatment: A Patient Guide Patients: Your doctor or nurse will go over this patient guide with you. It is important to ask any questions

More information

Getting started with PROMACTA (eltrombopag)

Getting started with PROMACTA (eltrombopag) Getting started with PROMACTA (eltrombopag) Indications PROMACTA is a prescription medicine used to treat adults and children 1 year and older with low blood platelet counts due to chronic immune (idiopathic)

More information

Tuscarawas County Health Department. Vivitrol Treatment Consent

Tuscarawas County Health Department. Vivitrol Treatment Consent Tuscarawas County Health Department Vivitrol Treatment Consent I. Vivitrol Medication Guide: a. VIVITROL (viv-i-trol) (naltrexone for extended-release injectable suspension) b. Read this Medication Guide

More information

Learning More Can Make a Difference

Learning More Can Make a Difference When your advanced or metastatic HER2+ breast cancer progresses on an anthracycline, a taxane, and Herceptin (trastuzumab) T U R N T O T Y K E R B + C A P E C I T A B I N E Learning More Can Make a Difference

More information

MEDICATION GUIDE Abacavir, Lamivudine and Zidovudine Tablets (a-bak-a-vir, la-miv-ue-deen, zye-doe-vue-deen)

MEDICATION GUIDE Abacavir, Lamivudine and Zidovudine Tablets (a-bak-a-vir, la-miv-ue-deen, zye-doe-vue-deen) MEDICATION GUIDE Abacavir, Lamivudine and Zidovudine Tablets (a-bak-a-vir, la-miv-ue-deen, zye-doe-vue-deen) What is the most important information I should know about abacavir, lamivudine and zidovudine

More information

You Have the Power to Take Action

You Have the Power to Take Action LARTRUVO + DOXORUBICIN FOR SOFT TISSUE SARCOMA You Have the Power to Take Action A soft tissue sarcoma diagnosis can be a shock. Understanding your treatment can make a difference. WHO IS LARTRUVO FOR?

More information

LIVE LONGER. Chart a course that could help you. If multiple myeloma comes back:

LIVE LONGER. Chart a course that could help you. If multiple myeloma comes back: 1 If multiple myeloma comes back: Chart a course that could help you 1 LIVE LONGER -3 In two clinical studies with patients with relapsed multiple myeloma, two KYPROLIS -based combinations kept multiple

More information

Patient Information. VIREAD (VEER-ee-ad) (tenofovir disoproxil fumarate) tablets. (tenofovir disoproxil fumarate) oral powder

Patient Information. VIREAD (VEER-ee-ad) (tenofovir disoproxil fumarate) tablets. (tenofovir disoproxil fumarate) oral powder Patient Information tablets oral powder Read this Patient Information before you start taking VIREAD and each time you get a refill. There may be new information. This information does not take the place

More information

WORTH A CLOSER LOOK.

WORTH A CLOSER LOOK. A birth control pill... WORTH A CLOSER LOOK. Ask your healthcare provider about. Please see Important Safety Information including Boxed Warning throughout this brochure and on pages 4 and 5. offers a

More information

Discussion guide. Questions to bring to your next doctor s appointment. Notes

Discussion guide. Questions to bring to your next doctor s appointment. Notes Discussion guide Questions to bring to your next doctor s appointment As someone who has had a heart attack or has peripheral arterial disease (PAD), it s important to lower your chance of having a heart

More information

Get an Insurance Benefits Review for ORENCIA (abatacept)

Get an Insurance Benefits Review for ORENCIA (abatacept) Get an Insurance Benefits Review for ORENCIA (abatacept) If you and your doctor decide that ORENCIA is right for you, you can call 1-800-ORENCIA (1-800-673-6242) to do an Insurance Benefits Review. Our

More information

AVEED TESTOSTERONE INJECTION. Not an actual patient.

AVEED TESTOSTERONE INJECTION. Not an actual patient. Ask your healthcare provider about LONG-ACTING AVEED AVEED TESTOSTERONE INJECTION 5 SHOTS A YEAR AFTER THE FIRST MONTH OF THERAPY Not an actual patient. AVEED is a prescription medicine that contains testosterone,

More information

Take CYCLOSET exactly as instructed by your health care provider, and be sure to read the Patient Information section of the package insert.

Take CYCLOSET exactly as instructed by your health care provider, and be sure to read the Patient Information section of the package insert. To help adults control type 2 diabetes along with diet and exercise UNLOCK YOUR INSULIN POTENTIAL A once-daily treatment that works in the brain to help you become more responsive to the insulin in your

More information

Watch Now! Hear real patients and experts. Search for our Facing CIU Channel.

Watch Now! Hear real patients and experts. Search for our Facing CIU Channel. Watch Now! Hear real patients and experts. Search for our Facing CIU Channel. Plus, get the CIU Tracker app XOL/012215/0008a(4) 1 1/17 If antihistamines aren t enough for your chronic hives where the cause

More information

Patient s guide for switching to

Patient s guide for switching to Patient s guide for switching to ENVARSUS XR is taken just once a day. ENVARSUS XR is a tablet; it is the only tacrolimus product available in tablet form. All Day ENVARSUS XR is not substitutable with

More information

Could your uncontrollable movements be tardive dyskinesia (TD)? There s a treatment with INGREZZA.

Could your uncontrollable movements be tardive dyskinesia (TD)? There s a treatment with INGREZZA. Lip smacking, eye blinking, dancing hands and fingers, hip jerking... Could your uncontrollable movements be tardive dyskinesia (TD)? There s a treatment with INGREZZA. Approved for adults with TD TD can

More information

ARIKAYCE IMPORTANT SAFETY INFORMATION

ARIKAYCE IMPORTANT SAFETY INFORMATION ARIKAYCE The first and only FDA-approved medication for the treatment of refractory (difficult to treat) MAC lung disease as part of a combination antibacterial drug treatment plan MAC=Mycobacterium avium

More information

Important Safety Information About TRUVADA to Reduce the Risk of Getting Human Immunodeficiency Virus 1 (HIV-1) Infection

Important Safety Information About TRUVADA to Reduce the Risk of Getting Human Immunodeficiency Virus 1 (HIV-1) Infection Important Safety Information About TRUVADA to Reduce the Risk of Getting Human Immunodeficiency Virus 1 (HIV-1) Infection This booklet is for adults taking TRUVADA to reduce the risk of getting HIV-1 infection.

More information

MEDICATION GUIDE. BENLYSTA (ben-list-ah) (belimumab) Injection for intravenous use

MEDICATION GUIDE. BENLYSTA (ben-list-ah) (belimumab) Injection for intravenous use MEDICATION GUIDE BENLYSTA (ben-list-ah) (belimumab) Injection for intravenous use Read this Medication Guide before you start receiving BENLYSTA and before each treatment. There may be new information.

More information

Patient Information VIREAD (VEER-ee-ad) (tenofovir disoproxil fumarate) tablets and oral powder

Patient Information VIREAD (VEER-ee-ad) (tenofovir disoproxil fumarate) tablets and oral powder Patient Information VIREAD (VEER-ee-ad) (tenofovir disoproxil fumarate) tablets and oral powder Read this Patient Information before you start taking VIREAD and each time you get a refill. There may be

More information

Open to the possibility of a multiple myeloma treatment that works in cells in your body at the DNA level

Open to the possibility of a multiple myeloma treatment that works in cells in your body at the DNA level If you have multiple myeloma and have already tried at least 2 other types of treatment Open to the possibility of a multiple myeloma treatment that works in cells in your body at the DNA level What is

More information

A treatment to fit your needs

A treatment to fit your needs A treatment to fit your needs Aranesp (darbepoetin alfa) is a prescription medicine used to treat a lower than normal number of red blood cells (anemia) caused by chronic kidney disease in patients on

More information

HELPING LIFT YOU THROUGH YOUR JOURNEY WITH SYMPTOMATIC SARCOIDOSIS

HELPING LIFT YOU THROUGH YOUR JOURNEY WITH SYMPTOMATIC SARCOIDOSIS HELPING LIFT YOU THROUGH YOUR JOURNEY WITH SYMPTOMATIC SARCOIDOSIS Your Guide to Acthar SUPPORTING YOU FROM THE START OF YOUR TREATMENT H.P. Acthar Gel is a prescription medicine for people with symptoms

More information

FDA APPROVED MEDICATION GUIDE

FDA APPROVED MEDICATION GUIDE FDA APPROVED MEDICATION GUIDE Valproic Acid Oral Solution Read this Medication Guide before you start taking valproic acid and each time you get a refill. There may be new information. This information

More information

Selected Important Safety Information

Selected Important Safety Information 60-DAY FREE * TRIAL See back cover for details *Limitations and restrictions apply. AMPYRA (dalfampridine) is the only branded prescription medicine indicated to help improve walking in adults with multiple

More information

Understanding your risk of blood clots from hospital to home and how Bevyxxa may help

Understanding your risk of blood clots from hospital to home and how Bevyxxa may help Understanding your risk of blood clots from hospital to home and how Bevyxxa may help People who take Bevyxxa and have medicine injected into their spinal and epidural area, or have a spinal puncture,

More information

UNDERSTANDING HAIR THINNING/HAIR LOSS

UNDERSTANDING HAIR THINNING/HAIR LOSS UNDERSTANDING HAIR THINNING/HAIR LOSS INDICATION AUBAGIO (teriflunomide) is indicated for the treatment of patients with relapsing forms of multiple sclerosis. IMPORTANT SAFETY INFORMATION WARNING: HEPATOTOXICITY

More information

Welcome to Mirena. The Mirena Handbook: A Personal Guide to Your New Mirena. mirena.com. Mirena is the #1 prescribed IUD * in the U.S.

Welcome to Mirena. The Mirena Handbook: A Personal Guide to Your New Mirena. mirena.com. Mirena is the #1 prescribed IUD * in the U.S. Mirena is the #1 prescribed IUD * in the U.S. Welcome to Mirena The Mirena Handbook: A Personal Guide to Your New Mirena *Intrauterine Device Supported by 2015-2016 SHS data INDICATIONS FOR MIRENA Mirena

More information

GLEEVEC PATIENT RESOURCES

GLEEVEC PATIENT RESOURCES GLEEVEC TALKING WITH YOUR DOCTOR ABOUT KIT+ GIST AND ITS TREATMENT When you have KIT-positive gastrointestinal stromal tumor (KIT+ GIST), you will likely have many questions and may, at times, feel overwhelmed

More information

What you need to know as you begin your treatment for symptomatic neurogenic orthostatic hypotension (noh)

What you need to know as you begin your treatment for symptomatic neurogenic orthostatic hypotension (noh) SEE IF YOU CAN BREAK FREE WITH NORTHERA (droxidopa) What you need to know as you begin your treatment for symptomatic neurogenic orthostatic hypotension (noh) Use NORTHERA (droxidopa) is a prescription

More information

The ORENCIA (abatacept) JIA Observational Registry

The ORENCIA (abatacept) JIA Observational Registry Moderate to Severe Juvenile Idiopathic Arthritis (JIA) Injection for Intravenous Use Injection for Subcutaneous Use The ORENCIA (abatacept) JIA Observational Registry Injection for Intravenous Use Injection

More information

treatment calendar Hilde D. EMPLICITI patient Looking forward to what s ahead

treatment calendar Hilde D. EMPLICITI patient Looking forward to what s ahead treatment calendar Hilde. MPLICITI patient Looking forward to what s ahead The story behind the selfie: Hilde Hilde. MPLICITI patient njoying custard at our favorite shop My family is really important

More information